[Hub]/) : Traits : Medication: Simvastatin :

chr19:10,283,932-12,191,233

Best TWAS P=3.29e-13 · Best GWAS P=6.99e-38 conditioned to 5.35e-12

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 GTEx Adipose Subcutaneous EPOR 0.11 0.04 lasso 7 0.04 3.8e-04 -7.2 -7.1 1.4e-12 0.48 0.52 0.38 TRUE
2 GTEx Cells Transformed fibroblasts CARM1 0.11 0.01 lasso 4 0.00 6.9e-01 -5.0 -5.3 1.4e-07 0.35 0.29 0.04 FALSE
3 GTEx Esophagus Mucosa SMARCA4 0.18 0.03 enet 15 0.09 8.2e-07 -4.5 6.0 2.3e-09 -0.36 0.95 0.00 FALSE
4 GTEx Esophagus Muscularis SMARCA4 0.16 0.00 lasso 6 0.03 7.2e-03 -7.3 5.2 1.8e-07 -0.39 0.17 0.08 FALSE
5 GTEx Pancreas LDLR 0.19 -0.01 enet 5 0.01 9.7e-02 1.3 -6.2 4.2e-10 0.50 0.02 0.71 TRUE
6 NTR Blood SMARCA4 0.07 0.06 lasso 11 0.06 9.0e-18 -5.8 5.8 7.6e-09 -0.38 1.00 0.00 FALSE
7 ROSMAP Brain Pre-frontal Cortex C19orf80 0.08 0.04 enet 17 0.05 3.1e-07 2.6 7.3 3.3e-13 -0.41 0.65 0.33 TRUE
8 YFS Blood SMARCA4 0.02 0.01 enet 3 0.00 9.2e-03 -4.3 5.9 3.0e-09 -0.39 0.15 0.07 FALSE
9 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma C19orf52 0.04 0.04 blup 27 0.03 1.7e-04 -5.5 5.3 8.8e-08 -0.37 0.00 1.00 FALSE
10 The Cancer Genome Atlas Prostate Adenocarcinoma SPC24 0.06 0.00 enet 15 0.01 1.4e-02 -9.9 7.3 3.7e-13 -0.35 0.00 0.55 FALSE
11 The Cancer Genome Atlas Thyroid Carcinoma C19orf52 0.05 0.06 lasso 4 0.06 2.5e-06 -4.9 5.5 4.2e-08 -0.36 0.01 0.99 FALSE